Bioinformatics Advance Access published online on February 18, 2007
Bioinformatics, doi:10.1093/bioinformatics/btm058
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A new JAVA interface implementation of THESIAS: Testing Haplotype EffectS In Association Studies
INSERM, UMR S 525, and Université Pierre et Marie Curie-Paris6, UMR S 525; Paris, France
*To whom correspondence should be addressed. Dr. David-Alexandre Tregouet, E-mail: david.tregouet{at}chups.jussieu.fr
| Abstract |
|---|
Summary: THESIAS is a popular software for carrying haplotype association analysis in unrelated individuals. In addition to the command line interface, a graphical JAVA interface is now proposed allowing one to run THESIAS in an user-friendly manner. Besides, new functionalities have been added to THESIAS including the possibility to analyse polychotomous phenotype and X-linked polymorphisms.
Availability: The software package including documentation and example data files is freely available at http://genecanvas.ecgene.net/. The source codes are also available upon request.
Associate Editor: Martin Bishop
Received on December 26, 2006; revised on February 9, 2007; accepted on February 9, 2007
This article has been cited by other articles:
![]() |
E. A Garcia, P. King, K. Sidhu, H. Ohgusu, A. Walley, C. Lecoeur, M. Gueorguiev, S. Khalaf, D. Davies, A. B Grossman, et al. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes Eur. J. Endocrinol., August 1, 2009; 161(2): 307 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Goekkurt, S.-E. Al-Batran, J. T. Hartmann, U. Mogck, G. Schuch, M. Kramer, E. Jaeger, C. Bokemeyer, G. Ehninger, and J. Stoehlmacher Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie J. Clin. Oncol., June 10, 2009; 27(17): 2863 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Debette, S. Bevan, J.-F. Dartigues, M. Sitzer, M. Lorenz, P. Ducimetiere, P. Amouyel, and H. S. Markus Fractalkine Receptor/Ligand Genetic Variants and Carotid Intima-Media Thickness Stroke, June 1, 2009; 40(6): 2212 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Regieli, J. W. Jukema, D. E. Grobbee, J. J.P. Kastelein, J. A. Kuivenhoven, A. H. Zwinderman, Y. van der Graaf, M. L. Bots, and P. A. Doevendans CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction Eur. Heart J., November 2, 2008; 29(22): 2792 - 2799. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-A. Tregouet, P.-H. Groop, S. McGinn, C. Forsblom, S. Hadjadj, M. Marre, H.-H. Parving, L. Tarnow, R. Telgmann, T. Godefroy, et al. G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes Diabetes, October 1, 2008; 57(10): 2843 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schunkert, A. Gotz, P. Braund, R. McGinnis, D.-A. Tregouet, M. Mangino, P. Linsel-Nitschke, F. Cambien, C. Hengstenberg, K. Stark, et al. Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease Circulation, April 1, 2008; 117(13): 1675 - 1684. [Abstract] [Full Text] [PDF] |
||||





